Laurence Albigès

Research interests

Publications

• European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update

  European Urology · 2025 · https://doi.org/10.1016/j.eururo.2025.02.020

• Renal cell carcinoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

  Annals of Oncology · 2024 · https://doi.org/10.1016/j.annonc.2024.05.537

• Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome

  Cell · 2024 · https://doi.org/10.1016/j.cell.2024.05.029

• A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers

  Science · 2023 · https://doi.org/10.1126/science.abo2296

• Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial

  The Lancet · 2022 · https://doi.org/10.1016/s0140-6736(22)01658-0

• European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update

  European Urology · 2022 · https://doi.org/10.1016/j.eururo.2022.03.006

• Impact of COVID-19 on healthcare organisation and cancer outcomes

  European Journal of Cancer · 2021 · https://doi.org/10.1016/j.ejca.2021.05.012

• Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial

  Nature Medicine · 2020 · https://doi.org/10.1038/s41591-020-1044-8

• Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus

  Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.07.010

• Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report

  Annals of Oncology · 2020 · https://doi.org/10.1016/j.annonc.2020.03.300

• Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients

  European Urology · 2020 · https://doi.org/10.1016/j.eururo.2020.04.044

• Cross-reactivity between tumor MHC class I–restricted antigens and an enterococcal bacteriophage

  Science · 2020 · https://doi.org/10.1126/science.aax0701

• Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

  New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1816047

• Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma

  New England Journal of Medicine · 2018 · https://doi.org/10.1056/nejmoa1803675

• Haematological immune-related adverse events induced by anti-PD-1 or anti-PD-L1 immunotherapy: a descriptive observational study

  The Lancet Haematology · 2018 · https://doi.org/10.1016/s2352-3026(18)30175-3

• Safety and efficacy of anti-programmed death 1 antibodies in patients with cancer and pre-existing autoimmune or inflammatory disease

  European Journal of Cancer · 2018 · https://doi.org/10.1016/j.ejca.2017.12.008

• Renal cell carcinoma

  Nature Reviews Disease Primers · 2017 · 10.1038/nrdp.2017.9

• Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

  Science · 2017 · https://doi.org/10.1126/science.aan3706

• Immunomodulatory Activity of Nivolumab in Metastatic Renal Cell Carcinoma

  Clinical Cancer Research · 2016 · https://doi.org/10.1158/1078-0432.ccr-15-2839

• Body Mass Index and Metastatic Renal Cell Carcinoma: Clinical and Biological Correlations

  Journal of Clinical Oncology · 2016 · https://doi.org/10.1200/jco.2016.66.7311

• Androgen Deprivation Therapy (ADT) Plus Docetaxel Versus ADT Alone in Metastatic Non castrate Prostate Cancer: Impact of Metastatic Burden and Long-term Survival Analysis of the Randomized Phase 3 GETUG-AFU15 Trial

  European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.11.005

• Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data

  The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00489-1

• Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia-inducible Factor-2 Alpha, is Regulated by von Hippel–Lindau Gene Mutation Status

  European Urology · 2015 · https://doi.org/10.1016/j.eururo.2015.11.029

• Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)

  Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt136

Current projects

No projects listed.